http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Press+Releases/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html <p> <i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.</i> </p> <p> JUPITER, Fla.--(BUSINESS WIRE)-- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. </p><p> <b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing</b> critical raw materials — enzymes, nucleotides, cap http://www.streetinsider.com/Business+Wire/TriLink+Opens+GMP+Enzyme+Manufacturing+Facility%2C+Enabling+Integrated+IVT+Supply+from+R%26amp%3BD+to+Commercial+Scale/26650989.html Tue, 16 Jun 2026 08:30:00 -0400 A.50204872 MRVI O.00184580 O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+ORESHACK+KURT/26630782.html si-local-file:///var/storage/secattach/20260610/26630782.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+ORESHACK+KURT/26630782.html Wed, 10 Jun 2026 17:07:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+ORESHACK+KURT/26630782.html si-local-file:///var/storage/secattach/20260610/26630782.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+ORESHACK+KURT/26630782.html Wed, 10 Jun 2026 17:07:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+08++Filed+by%3A+Brust+Bernd/26630784.html si-local-file:///var/storage/secattach/20260610/26630784.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+08++Filed+by%3A+Brust+Bernd/26630784.html Wed, 10 Jun 2026 17:07:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+08++Filed+by%3A+Brust+Bernd/26630784.html si-local-file:///var/storage/secattach/20260610/26630784.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+08++Filed+by%3A+Brust+Bernd/26630784.html Wed, 10 Jun 2026 17:07:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+LUCIER+GREGORY+T/26630776.html si-local-file:///var/storage/secattach/20260610/26630776.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+LUCIER+GREGORY+T/26630776.html Wed, 10 Jun 2026 17:06:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+LUCIER+GREGORY+T/26630776.html si-local-file:///var/storage/secattach/20260610/26630776.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+09++Filed+by%3A+LUCIER+GREGORY+T/26630776.html Wed, 10 Jun 2026 17:06:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26628736.html si-local-file:///var/storage/secattach/20260610/26628736.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26628736.html Wed, 10 Jun 2026 12:00:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26628736.html si-local-file:///var/storage/secattach/20260610/26628736.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26628736.html Wed, 10 Jun 2026 12:00:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26622075.html si-local-file:///var/storage/secattach/20260609/26622075.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26622075.html Tue, 09 Jun 2026 10:32:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26622075.html si-local-file:///var/storage/secattach/20260609/26622075.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+ORESHACK+KURT/26622075.html Tue, 09 Jun 2026 10:32:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+02/26596014.html si-local-file:///var/storage/secattach/20260603/26596014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+02/26596014.html Wed, 03 Jun 2026 08:32:00 -0400 MRVI O.49219148 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+02/26596014.html si-local-file:///var/storage/secattach/20260603/26596014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+02/26596014.html Wed, 03 Jun 2026 08:32:00 -0400 MRVI O.49219148 http://www.streetinsider.com/Corporate+News/Maravai+LifeSciences+refinances+debt%2C+reduces+principal+by+%2492.9+million/26595971.html <p>Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI) announced that its subsidiaries entered into a new credit agreement providing a $150 million term loan facility and a $30 million revolving credit facility.</p> <p>The company used borrowings from the new term loan facility and approximately $98.5 million of cash on hand to prepay outstanding borrowings under its previous credit agreement that was due in October 2027.</p> <p>The refinancing reduces Maravai's long-term debt from approximately $242.9 million in outstanding principal to $150.0 million in outstanding principal. The new term loan extends the maturity date to June 2032 while maintaining access to additional liquidity through the revolving http://www.streetinsider.com/Corporate+News/Maravai+LifeSciences+refinances+debt%2C+reduces+principal+by+%2492.9+million/26595971.html Wed, 03 Jun 2026 08:30:42 -0400 MRVI O.49219148 http://www.streetinsider.com/Corporate+News/Maravai+LifeSciences+refinances+debt%2C+reduces+principal+by+%2492.9+million/26595971.html <p>Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI) announced that its subsidiaries entered into a new credit agreement providing a $150 million term loan facility and a $30 million revolving credit facility.</p> <p>The company used borrowings from the new term loan facility and approximately $98.5 million of cash on hand to prepay outstanding borrowings under its previous credit agreement that was due in October 2027.</p> <p>The refinancing reduces Maravai's long-term debt from approximately $242.9 million in outstanding principal to $150.0 million in outstanding principal. The new term loan extends the maturity date to June 2032 while maintaining access to additional liquidity through the revolving http://www.streetinsider.com/Corporate+News/Maravai+LifeSciences+refinances+debt%2C+reduces+principal+by+%2492.9+million/26595971.html Wed, 03 Jun 2026 08:30:42 -0400 MRVI O.49219148 http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html <p> SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that certain of its subsidiaries have entered into a new credit agreement providing the Company with a $150 million term loan facility and a $30 million revolving credit facility. </p><p> Borrowings under the new term loan facility, together with approximately $98.5 million of cash on hand, were used to prepay outstanding borrowings under the Company’s prior credit agreement due October 2027. </p><p> The transaction reduces the Company’s long-term debt from approximately $242.9 million in aggregate outstanding http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html Wed, 03 Jun 2026 08:30:00 -0400 MRVI O.49219148 http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html <p> SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that certain of its subsidiaries have entered into a new credit agreement providing the Company with a $150 million term loan facility and a $30 million revolving credit facility. </p><p> Borrowings under the new term loan facility, together with approximately $98.5 million of cash on hand, were used to prepay outstanding borrowings under the Company’s prior credit agreement due October 2027. </p><p> The transaction reduces the Company’s long-term debt from approximately $242.9 million in aggregate outstanding http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html Wed, 03 Jun 2026 08:30:00 -0400 MRVI O.49219148 http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html <p> SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that certain of its subsidiaries have entered into a new credit agreement providing the Company with a $150 million term loan facility and a $30 million revolving credit facility. </p><p> Borrowings under the new term loan facility, together with approximately $98.5 million of cash on hand, were used to prepay outstanding borrowings under the Company’s prior credit agreement due October 2027. </p><p> The transaction reduces the Company’s long-term debt from approximately $242.9 million in aggregate outstanding http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+Announces+Refinancing+of+Credit+Agreement%2C+Extending+Maturity+to+2032/26595948.html Wed, 03 Jun 2026 08:30:00 -0400 MRVI O.49219148